Kleinsteuber v. Metropolitan Life Insurance Company

Background

Plaintiff Charles Kleinsteuber and his wife Dana held a group Accidental Death and Dismemberment (AD&D) insurance policy issued by Defendant Metropolitan Life Insurance Company (MetLife) through Charles's employer. Dana was diagnosed with end-stage renal disease (ESRD) in 2021 and began self-administering home dialysis treatments.

On January 18, 2022, Dana was self-administering dialysis at home with plans to go to lunch afterward. Charles called her at 11:25 a.m. and she sounded normal, saying she was about to finish treatment. When Charles returned home at 11:55 a.m., he found Dana lying in a pool of blood. She told him, "I think I may have killed myself." Emergency responders arrived at 12:23 p.m., but Dana was pronounced dead at 1:08 p.m. Charles told first responders that Dana had not ended her dialysis properly — she had not closed her port on her right upper chest, and she panicked when the dialysis machine alarmed, dislodging her line. The Carver County Medical Examiner listed her cause of death as ESRD and manner of death as natural. Dana's death certificate listed immediate cause of death as ESRD and underlying cause as natural causes.

MetLife paid out a separate life insurance claim but denied the AD&D claim. After a formal review and an appeal (during which Kleinsteuber submitted extensive records including a letter from Dana's treating physician, Dr. Kelly Flynn, stating that Dana's death was caused by the accident and not contributed to by her ESRD or its treatment), MetLife upheld its denial. MetLife's appeal decision focused on the policy exclusion, reasoning that because dialysis is a treatment for ESRD, and Dana would not have had a port line or been interacting with a dialysis machine but for that treatment, the dialysis treatment caused or contributed to her death.

Kleinsteuber filed this action under the Employee Retirement Income Security Act of 1974 (ERISA), the federal law governing employer-sponsored benefit plans, seeking the full AD&D benefit plus interest and attorney's fees. Both parties moved for summary judgment.

Legal Framework

Summary judgment is appropriate when there are no genuine disputes of material fact and the moving party is entitled to judgment as a matter of law. Under ERISA, courts review benefit denials "de novo" (without deference) unless the plan unambiguously grants the administrator discretion, in which case courts apply the more deferential "abuse of discretion" standard. Under that standard, an administrator's interpretation is upheld unless it is unreasonable. The parties agreed the abuse of discretion standard applied here. MetLife also conceded at the summary judgment stage that Dana's death was accidental.

The remaining question was whether MetLife abused its discretion in applying the policy exclusion — which bars benefits for any loss "caused or contributed to" by the "treatment" of a physical illness — to Dana's death.

The court applied a two-step analysis: (1) whether MetLife's interpretation of the exclusion was reasonable, assessed using the five Finley factors from the Eighth Circuit, and (2) whether application of that interpretation was supported by substantial evidence in the record.

The Finley Factors

Factor 1: Consistency with Goals of the Plan The court found this factor weighed slightly in favor of MetLife. While covering an accidental port dislodgment would be consistent with the general goal of an AD&D plan, insurers commonly include illness/treatment exclusions to hedge against heightened medical risks, which allows them to offer lower premiums. A plan need not pursue its primary goal to the exclusion of all others.

Factor 2: Rendering Policy Language Meaningless Kleinsteuber argued MetLife blurred the distinction between the "accident" and the "loss" by treating the dialysis as the cause of the accident rather than the cause of the death. The court disagreed, finding that MetLife's denial letters used "loss" to refer to Dana's death — not the accident — and thus the interpretation did not render the word "loss" meaningless. This factor weighed in favor of MetLife.

Factor 3: Conflicts with ERISA's Procedural Requirements Kleinsteuber alleged MetLife failed to: (1) explain specific reasons for denial, (2) describe what additional information was needed to perfect the claim, (3) inform him of his right to all relevant information, and (4) consider all evidence he submitted.

The court found MetLife adequately explained the denial reasons and did inform Kleinsteuber of his right to relevant records. However, the court found MetLife's initial denial letter was "at least somewhat defective" in failing to specify what additional information would be needed to perfect the claim — the letter's general invitation to submit "any pertinent documentation" fell short of the regulatory requirement for specificity. Nevertheless, the court found the overall course of MetLife's communications was "substantively equivalent" to ERISA's requirements and fairly positioned Kleinsteuber to pursue his appeal. The court also noted that because the dispute was primarily one of interpretation rather than lack of evidence, it was unclear what additional information could have changed the outcome. The court found MetLife conducted a full and fair review, and this factor weighed in favor of MetLife.

Factor 4: Consistent Interpretation The court found MetLife had consistently applied the exclusion in similar cases nationwide, including situations involving botched surgeries or medical procedures that contributed to death. This factor weighed in favor of MetLife.

Factor 5: Clear Language of the Plan Kleinsteuber argued MetLife improperly used "related to" language (rather than the plan's "contributed to" standard) in portions of its denial letters. The court declined to resolve whether the two phrases are equivalent, finding that other portions of the denial letters did use the "contributes to" language of the exclusion. This factor weighed in favor of MetLife.

Additional Factor: Conflict of Interest The court recognized that MetLife has a conflict of interest because it both evaluates and pays out claims under the plan. Citing U.S. Supreme Court precedent (Metropolitan Life Ins. Co. v. Glenn), the court treated the conflict as one factor in the overall analysis. Comparing the case to a prior District of Minnesota decision (Hall v. Metro. Life Ins. Co.), the court found fewer aggravating factors here — no hidden evidence, no shifting rationale, no reliance on internal medical opinions not shared with the claimant. The court gave "minor to moderate weight" to the conflict of interest.

Overall Reasonableness All five Finley factors weighed in MetLife's favor. The court found the minor-to-moderate conflict of interest did not outweigh those factors, and concluded MetLife's interpretation of the exclusion was reasonable.

Substantial Evidence

The court found substantial evidence in the record that Dana's dialysis treatment contributed to her death. Dana was self-administering dialysis on the day she died; she failed to properly close her chest port; the dialysis machine alarmed and she dislodged the line; she died of acute blood loss. The court rejected Kleinsteuber's argument that whether the machine was switched off by the time of the port dislodgment was dispositive, reasoning that removing tubing and closing catheters is "part and parcel" of dialysis treatment.

The court also rejected the argument that causation was too remote. Citing cases from the Tenth Circuit (Kellogg v. Metro. Life Ins. Co.) and the Minnesota Supreme Court (Orman v. Prudential Ins. Co. of Am.), the court acknowledged that the exclusion does not apply when the illness merely causes an accident that in turn causes death — the treatment must directly contribute to the death itself. But the court distinguished those cases: in Kellogg, a seizure caused a car crash which caused a skull fracture; in Orman, an aneurysm caused a fall which caused drowning. Here, the botched dialysis, with no intervening steps, directly caused the fatal blood loss. The court found this more analogous to cases involving accidents during surgery where the treatment itself directly caused the fatal outcome.

Ruling

Judge Tunheim denied Kleinsteuber's motion for summary judgment and granted MetLife's motion for summary judgment, finding that MetLife did not abuse its discretion in denying the AD&D claim.